N. Hirani (Edinburgh (Edinburgh), United Kingdom), M. Funke-Chambour (Bern, Switzerland)
Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats
T. Yuan (Madison, United States), A. Nicholas (Madison, United States), N. Lakomski (Madison, United States), M. Afrazi (Madison, United States), H. Hamilton (Madison, United States), J. Hegge (Madison, United States), J. Hamilton (Madison, United States), T. Pei (Madison, United States), E. Bush (Madison, United States)
|   |
Fibroblast-like culture from bronchoalveolar lavage of patient with idiopathic pulmonary fibrosis
S. Gangi (siena, Italy), E. Bargagli (siena, Italy), M. D'Alessandro (siena, Italy), D. Cavallaro (siena, Italy), P. Cameli (siena, Italy), L. Bergantini (siena, Italy)
| |
Biomarker analysis of bronchoalveolar lavage (BAL), bronchoabsorption (BA) and serum in Idiopathic Pulmonary Fibrosis (IPF) and healthy volunteers (HV)
F. Li (Edinburgh, United Kingdom), A. Marshall (Edinburgh, United Kingdom), C. Boz (Edinburgh, United Kingdom), S. Mcnamara (Edinburgh, United Kingdom), L. Nicol (Edinburgh, United Kingdom), W. Bradford (Wilson, United States), N. Hirani (Edinburgh, United Kingdom)
| |
Dysfunctional club cells differentiation in idiopathic pulmonary fibrosis
B. SAISSAC (Montpellier, France), A. Bourdin (Montpellier, France), F. Aurélie (Montpellier, France)
| |
Mannose 6-phosphate/insulin-like growth factor 2 receptor in fibrosing phenotypes of diffuse parenchymal lung diseases
E. Tedlova (Bratislava, Slovakia), V. Leksa (Bratislava, Slovakia), M. Suchankova (Bratislava, Slovakia), E. Zsemlye (Bratislava, Slovakia), J. Urban (Vysne Hagy, Slovakia), M. Ganovska (Vysne Hagy, Slovakia), E. Tibenska (Bratislava, Slovakia), K. Szaboova (Bratislava, Slovakia), F. Sandor (Bratislava, Slovakia), M. Hajkova (Bratislava, Slovakia), K. Kluckova (Bratislava, Slovakia), M. Bucova (Bratislava, Slovakia)
| |
Discovery of intra-parenchymal adipose tissue as a component of tissue remodeling in pulmonary fibrosis
K. El Husseini (Paris, France), N. Poté (Paris, France), M. Jaillet (Paris, France), P. Mordant (Paris, France), H. Mal (Paris, France), J. Frija-Masson (Paris, France), R. Borie (Paris, France), A. Cazes (Paris, France), B. Crestani (Paris, France), A. Mailleux (Paris, France)
| |
Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts
C. Onursal (München, Germany), L. Knüppel (München, Germany), C. Lietman (Texas, United States), J. Merl-Pham (München, Germany), R. Hatz (München, Germany), J. Behr (München, Germany), K. Unger (München, Germany), J. Hess (München, Germany), S. Hauck (München, Germany), B. Lee (Texas, United States), C. Staab-Weijnitz (München, Germany)
| |
Role of IL17 A/F in experimental lung fibrosis
M. Moog (Hannover, Germany), F. Aschenbrenner (Hannover, Germany), D. Jonigk (Hannover, Germany), I. Prinz (Hannover, Germany), T. Welte (Hannover, Germany), M. Kolb (Hamilton, Canada), U. Maus (Hannover, Germany)
| |
Role of CXCL13 in animal model of lung fibrosis and human ILDs.
A. Watanbe (Kyoto, Japan), H. Koichi (Kyoto, Japan), . Shigeru (Kyoto, Japan), S. Kumal Gothwal (Kyoto, Japan), T. Handa (Kyoto, Japan), H. Date (Kyoto, Japan), T. Hirai (Kyoto, Japan), M. Haas (Wuppertal, Germany), F. Mcaleese Eser (Wuppertal, Germany), K. Fujimura (Wuppertal, Germany), J. Veerkamp (Wuppertal, Germany), H. Cernecka (Wuppertal, Germany), M. Koch (Wuppertal, Germany), U. Nielsch (Wuppertal, Germany), A. Sato (Kyoto, Japan)
| |
Idiopathic pulmonary fibrosis is associated with increased levels of FACIT collagen biomarkers
J. Sand (Herlev, Denmark), A. Hummersgaard Hansen (Herlev, Denmark), E. Madsen (Herlev, Denmark), J. Thorlacius-Ussing (Herlev, Denmark), T. Prior (Aarhus, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), E. Bendstrup (Aarhus, Denmark)
| |
Inhibitory role of retinoic acid-related orphan receptor alpha RORa in human lung fibroblast activation.
D. Zevla (Heraklion (Crete), Greece), E. Tsitoura (Heraklion (Crete), Greece), B. Crestani (Paris, France), K. Antoniou (Heraklion (Crete), Greece)
| |
Increased expression of ß-1,4-Galactosyltransferase-I in Idiopathic Pulmonary Fibrosis, a basis for further therapeutic applications
A. Ricci (Roma (RM), Italy), C. De Vitis (Roma (RM), Italy), D. Pizzirusso (Roma (RM), Italy), G. Guerrieri (Roma (RM), Italy), S. Castelli (Roma (RM), Italy), A. Carraturo (Roma (RM), Italy), A. Moretta (Roma (RM), Italy), C. Salvucci (Roma (RM), Italy), M. Chianese (Roma (RM), Italy), T. Sordi (Roma (RM), Italy), R. Mancini (Roma (RM), Italy), M. D'Ascanio (Roma (RM), Italy)
| |
PERIPHERAL BLOOD IMMUNOLOGICAL PROFILE OF IDIOPATHIC PULMONARY FIBROSIS
N. Mendoza Barco (Barcelona, Spain), S. Casas-Recasens (Barcelona, Spain), F. Hernandez (Barcelona, Spain), T. Cruz (Barcelona, Spain), N. Albacar (Barcelona, Spain), G. López-Saiz (Barcelona, Spain), X. Alzina (Barcelona, Spain), A. Agustí (Barcelona, Spain), J. Sellarés (Barcelona, Spain), R. Faner (Barcelona, Spain)
| |
Proteomic profiling for the development of new serum based diagnostic and prognostic biomarkers in Progressive Pulmonary Fibrosis.
E. Puxeddu (Roma (RM), Italy), G. Cillis (Roma (RM), Italy), L. Calzetta ( Parma (PR), Italy), F. Cavalli (RM (RM), Italy), G. Sergiacomi (RM (RM), Italy), I. Rossi (RM (RM), Italy), P. Rogliani (RM (RM), Italy)
| |
Expression of PD-1/PD-L1 axis and CD4/CD8 ratio in mediastinal lymph nodes of human and experimental lung fibrosis
T. Karampitsakos (Patras, Greece), A. Galaris (Athens, Greece), S. Chrysikos (Athens, Greece), O. Papaioannou (Patras, Greece), I. Vamvakaris (Athens, Greece), A. Anagnostopoulos (Athens, Greece), G. Stratakos (Athens, Greece), M. Katsaras (Patras, Greece), F. Sampsonas (Patras, Greece), K. Dimakou (Athens, Greece), E. Manali (Athens, Greece), S. Papiris (Athens, Greece), D. Bouros (Athens, Greece), P. Bakakos (Athens, Greece), V. Aidinis (Athens, Greece), A. Tzouvelekis (Patras, Greece)
| |
Bleomycine-induced Pulmonary fibrosis alters the functioning of the respiratory neural network
C. Yegen (Bobigny, France), D. Marchant (Bobigny, France), E. Boncoeur (Bobigny, France), n. voituron (Bobigny, France)
| |
Profibrotic effects analysis of bleomycin administration in Swiss CD-1 nude mice
K. Stiliyanov Atanasov (Palma de Mallorca, Spain), J. Truyols Vives (Palma de Mallorca, Spain), G. Escarrer (Palma de Mallorca, Spain), C. Gómez (Palma de Mallorca, Spain), T. De Francisco (Palma de Mallorca, Spain), A. Martín Medina (Palma de Mallorca, Spain), C. Río (Palma de Mallorca, Spain), E. Sala-Llinàs (Palma de Mallorca, Spain), J. Mercader-Barceló (Palma de Mallorca, Spain)
| |
Effects of a palmitate and fructose rich diet on lung fibrosis and inflammation markers in a murine model
K. Stiliyanov Atanasov (Palma de Mallorca, Spain), C. Gómez (Palma de Mallorca, Spain), J. Truyols Vives (Palma de Mallorca, Spain), A. Martín-Medina (Palma de Mallorca, Spain), G. Escarrer (Palma de Mallorca, Spain), E. Sala-Llinàs (Palma de Mallorca, Spain), J. Mercader-Barceló (Palma de Mallorca, Spain)
| |
Uncovering collagen VII in lungs of patients with idiopathic pulmonary fibrosis
B. Michaliková (Lund, Sweden), L. Xiong (Lund, Sweden), H. Brunnström (Lund, Sweden), A. Ibáñez-Fonseca (Lund, Sweden), S. Lundin (Gothenburg, Sweden), G. Dellgren (Gothenburg, Sweden), A. Löfdahl (Lund, Sweden), L. Elowsson Rendin (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden), A. Ibáñez Fonseca (Valladolid, Spain)
| |